PharmiWeb22h
Heart Valve Devices Market to Exceed US$ 38.2 Billion by 2034, Growing at a CAGR of 11.7% Amid Rising Cardiovascular Disease Burden | Analysis by TMR
Rising prevalence of cardiovascular diseases and rapid advancements in minimally invasive procedures are fueling the growth ...
MedPage Today on MSN1d
NCD for Tricuspid Valve Procedures; Flavanols & BP; Infective Endocarditis Up
Based on the finalized national coverage determination (NCD) for transcatheter tricuspid valve replacement, Medicare will ...
Scientific Research Publishing1d
Pulmonary Septic Emboli Following Endocarditis: A Case Report ()
Samman, A. and Babi, A. (2025) Pulmonary Septic Emboli Following Endocarditis: A Case Report. Open Journal of Clinical ...
TCTMD4d
CMS Agrees to Reimburse Transcatheter Tricuspid Valve Replacement
Payment will be provided when TTVR is delivered for an FDA-approved indication in the context of a CMS-approved study.
Frontiers5d
From Laboratory Insights to Clinical Strategies in Cardiogenic Shock
Cardiogenic shock remains a challenging clinical syndrome characterized by critically impaired cardiac output, systemic hypoperfusion, and high mortality ...
BioWorld6d
US Medicare’s TTVR aligns closely with draft, T-TEER devices en route
The final U.S. Medicare national coverage determination for transcatheter tricuspid valve replacement (TTVR) devices comes ...
Becker's Hospital Review6d
CMS approves coverage for transcatheter tricuspid valve replacement
CMS has approved Medicare and Medicaid coverage for transcatheter tricuspid valve replacement procedures for the treatment of ...
Laplace gains funding for transcatheter tricuspid valve replacement trial
Laplace Interventional, a US-based medical device company focusing on transcatheter valve technology, recently announced the ...